Trial ID or NCT#

NCT00375830

Status

not recruiting iconNOT RECRUITING

Purpose

This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate cancer.

Official Title

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Andrei Iagaru
Andrei Iagaru
Radiologist
Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center
Sanjiv Sam Gambhir, MD, PhD
Robert Herfkens
Robert Herfkens
Radiologist
Professor of Radiology (Cardiovascular Imaging)
Shreyas Vasanawala, MD/PhD
Shreyas Vasanawala, MD/PhD
Radiologist
Professor of Radiology (Pediatric Radiology)

Contact us to find out if this trial is right for you.

CONTACT

CCTO
(650) 498-7061